Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARILUMAB for Dermatitis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 5 adverse event reports in the FDA FAERS database where SARILUMAB was used for Dermatitis.

Most Reported Side Effects for SARILUMAB

Side Effect Reports % Deaths Hosp.
Drug ineffective 5,065 23.6% 662 898
Pain 4,833 22.5% 805 1,089
Arthralgia 4,139 19.3% 867 1,124
Rheumatoid arthritis 3,963 18.4% 894 1,276
Joint swelling 3,951 18.4% 826 1,026
Condition aggravated 3,247 15.1% 787 1,010
Fatigue 3,000 14.0% 821 1,097
Rash 2,912 13.6% 807 1,042
Alopecia 2,660 12.4% 874 1,136
Abdominal discomfort 2,600 12.1% 921 1,217
Hepatic enzyme increased 2,595 12.1% 861 1,129
Systemic lupus erythematosus 2,504 11.7% 942 1,144
Pemphigus 2,445 11.4% 901 1,070
Hand deformity 2,379 11.1% 873 1,047
Glossodynia 2,372 11.0% 868 1,044

Other Indications for SARILUMAB

Rheumatoid arthritis (14,766) Polymyalgia rheumatica (1,963) Product used for unknown indication (1,720) Covid-19 (265) Illness (130) Polyarthritis (103) Psoriatic arthropathy (94) Osteoarthritis (83) Arthritis (79) Psoriasis (75)

Other Drugs Used for Dermatitis

DUPILUMAB (9,959) CRISABOROLE (407) APREMILAST (122) TRALOKINUMAB-LDRM (90) KETOCONAZOLE (66) CYCLOSPORINE (62) DOXYCYCLINE (57) PIMECROLIMUS (55) CLOBETASOL (50) RUXOLITINIB (50)

Related Pages

SARILUMAB Full Profile All Dermatitis Drugs SARILUMAB Demographics SARILUMAB Timeline